SCHEMBL24848636

SCHEMBL24848636

CN(C)c1ccc(C(C)(C)C)cc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNH2 Q12809 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 3/20 0.34
TYR P14679 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181551 0.87 CYP1A2 (0.41) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL13166889 0.83 CYP1A2 (0.41) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL24433726 0.81 ALDH1A1 (0.39) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL24444043 0.80 KDM4E (0.39) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL16437229 0.80 ESR1 (0.50) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL20909917 0.78 ALDH1A1 (0.41) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL24237294 0.78 ALDH1A1 (0.39) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL14200425 0.77 KDM4E (0.44) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL12015335 0.77 CYP1A2 (0.40) CYP1A2CYP2C19ALDH1A1HPGDALOX15
SCHEMBL13528292 0.77 CYP1A2 (0.40) CYP1A2CYP2C19ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002417-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002417-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, ODC1 CYP1A2 303/4885CYP2C19 364/4885ALDH1A1 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.